Search
01/01/2024
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer
Catto, JWF, Tran, B, Rouprêt, M, Gschwend, JE, Loriot, Y, Nishiyama, H, Redorta, JP, Daneshmand, S, Hussain, SA, Cutuli, HJ, Procopio, G, Guadalupi, V, Vasdev, N, Naini, V, Crow, L, Triantos, S, Baig, M, Steinberg, G. Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer. ANNALS OF ONCOLOGY. 2024; 35(1)DOI:10.1016/j.annonc.2023.09.3116. PMID:37871701. IF:65.400(Q1/1D).
01/01/2024
Use of social media in radiation oncology: multicenter data from the GOCO Group
Bonet, M, Recalde, E, Soto, A, Martinez, A, Murcia, M, Mases, J, Fernandez, MN, Yufera, JC, Alvarez, A, Eraso, MA, Feltes, N, Hernandez, L, Bernard, P, Ramos, L, Garcia, V. Use of social media in radiation oncology: multicenter data from the GOCO Group. Reports Of Practical Oncology And Radiotherapy. 2024; 29(2)DOI:10.5603/rpor.100386. PMID:39143971. IF:(Q/D).
01/01/2024
Swallowing muscle training for oropharyngeal dysphagia: A non-inferiority study of online versus face-to-face therapy
Bascunana-Ambros, H, Renom-Guiteras, M, Nadal-Castells, MJ, Beranuy-Rodriguez, M, Perrot-Gonzalez, JC, Ramirez-Mirabal, E, Trejo-Omenaca, A, Monguet-Fierro, JM. Swallowing muscle training for oropharyngeal dysphagia: A non-inferiority study of online versus face-to-face therapy. JOURNAL OF TELEMEDICINE AND TELECARE. 2024; 30(1)DOI:10.1177/1357633X211035033. PMID:34355589. IF:3.200(Q2/3D).
01/01/2024
Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion
Fumagalli, C, Orellana, R, Ferre, M, Gonzalez, A, Catasus, L, Vazquez, T, Sebio, A, Lopez-Pousa, A, Llauger, J, Peiro, A, Antonescu, CR. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion. GENES CHROMOSOMES & CANCER. 2024; 63(1)DOI:10.1002/gcc.23215. PMID:38050902. IF:2.800(Q2/5D).